For the Inventor, By the Inventor

Enter assignee name

Seoul, South Korea

Exocobio Inc.

USPTO Granted Patents = 12

EPO Patents = 5

Trademarks = 10

Forward Citations = 9

Loading Chart...

Loading Chart...

9 inventors (with patents filed for the assignee):

Byong Seung Cho (12 out of 12 patents)

Yong Weon Yi (9 out of 9 patents)

Kwang Il Kim (2 out of 2 patents)

4. So Young Lee (1 out of 173 patents)

5. Ji Hyun Seo (1 out of 19 patents)

6. Kwang Ii Kim (1 out of 1 patent)

7. Sung Hun Youn (1 out of 2 patents)

8. Mu Hyun Jin (1 out of 5 patents)

9. Yu Jin Won (1 out of 1 patent)

12 patents: Sort by Forward Citations

1. 12636337 - Composition for anti-inflammation, wound healing or wound healing promotion, comprising rose stem cell-derived exosomes as active ingredient (2026-05-26),

2. 12605331 - Composition comprising iris-derived exosome as active ingredient (2026-04-21),

3. 12491151 - Cosmetic composition comprising black yeast-derived exosomes (2025-12-09),

4. 11850297 - Composition comprising sapogenin and exosome as effective ingredient (2023-12-26),

5. 11730695 - Composition for alleviating facial redness, comprising stem cell-derived exosomes as active ingredient (2023-08-22),

6. 11690797 - Cosmetic composition comprising rose stem cell-derived exosome as effective ingredient (2023-07-04),

7. 11612621 - Use of composition comprising exosome derived from adipose-derived stem cell as effective ingredient in ameliorating dermatitis (2023-03-28),

8. 11534392 - Cosmetic composition comprising exosomes derived from galactomyces as active ingredient (2022-12-27),

9. 11529370 - Use of composition comprising stem cell-derived exosome as effective ingredient in strengthening skin barrier and improving skin barrier function (2022-12-20),

10. 11529306 - Lyophilized formulation of stem cell-derived exosomes and anti-inflammatory composition including the same as active ingredient (2022-12-20),

11. 11446333 - Use of composition comprising stem cell-derived exosome as effective ingredient for suppression or alleviation of pruritus (2022-09-20),

12. 11337419 - Method for lyophilizing exosome (2022-05-24),

Exocobio Inc. is a leading biotech company specializing in the research and development of exosome-based products for regenerative medicine and cosmetics. With state-of-the-art technology and a team of experienced scientists, we are committed to providing innovative solutions for improving human health and beauty. Visit our website to learn more about our products and services.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

12 Patents

#343 in Seoul

#932 in South Korea

#48,090 in the World

Seoul, South Korea

Exocobio Inc.

Forward Citations = 9

9 inventors:

Byong Seung Cho (12 out of 12 patents)

Yong Weon Yi (9 out of 9 patents)

Kwang Il Kim (2 out of 2 patents)

4. So Young Lee (1 out of 173 patents)

5. Ji Hyun Seo (1 out of 19 patents)

Please report any incorrect information to [email protected]

Loading…